The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Human Epigenome project launched

15 February 2010
Appeared in BioNews 545

The sequel to the Human Genome Project, the International Human Epigenome Consortium (IHEC), has arrived and may hold the key to treating intractable diseases such as cancer and obesity. Recent studies mapping epigenetics - chemical modifications of DNA that affect gene expression - have shown how important understanding the epigenome is for health and disease.

IHEC was launched in Paris last week, and has ambitious plans to map 1,000 reference epigenomes within a decade. This will allow researchers to compare their findings with a robust and trustworthy template. According to Peter Jones, University of Southern California, US, speaking for IHEC in Paris, the project was also spurred on by a growing number of publications on epigenetics, which he says is why researchers need to agree now on how to standardise data.

In contrast to mapping the human genome, which is described as 'finite, the human epigenome is almost infinite — the epigenome changes in different states and different tissues', explains Philip Avner of the Pasteur Institute in Paris, a member of IHEC's steering committee. Incidentally, the seemingly epic challenge IHEC has set itself has raised doubts among some scientists at the meeting, according to a Nature news article, and as a result there are concerns the project is premature.

Dr Jones gave his reasons for why science is ready for IHEC: 'But this is exactly the point of launching IHEC now — to avoid confusion and move the field forward more quickly'. A point expanded on by Dr Avner, who said, 'When we have all the references, we'll be able to compare diseased tissue against them', which is a similar model to how we currently locate genetic diseases.

Jeanne Loring of the Scripps Research Institute and her colleagues have shown in a recent Genome Research publication how DNA methylation, a type of epigenetic control, changes during cell differentiation. Their research provides one of the first comprehensive epigenetic maps and indicates the importance of mapping the human epigenome, considering that the control of differentiation is connected to the development of cancer.

Further applications for these findings include using the maps as a reference for what stage of differentiation a cell is at which, for example, is useful as a quality control for induced pluripotent stem cell (iPS cell)  production and research. iPS cells, like embryonic stem cells (ES cells), can be used to study differentiation and potentially provide tissue transplants. However, unlike ES cells, iPS cells are originally extracted from a living organism or the patient, which avoids ethical issues and offers greater compatibility for transplant.

In addition to a more advanced understanding of genetic disease, a map of the human epigenome may also pick up the slack from the Human Genome Project. Contrary to previous expectations, genetic variation alone cannot explain the extent of the diversity seen in nature. Whereas an extra layer of heritable information, i.e. the epigenome, could account for the variation seen between species with similar genetic makeup.

Mapping methylation
The Scientist |  3 February 2010
Project set to map marks on genome
Nature |  2 February 2010
Time for the epigenome
Nature |  4 February 2010
23 February 2015 - by Meghna Kataria 
Scientists have unveiled a map of the human epigenome - the suite of molecular controllers which turn genes on and off in every human cell...
10 September 2012 - by Dr Daniel Grimes 
In her new book, 'The Epigenetics Revolution', Nessa Carey argues that we are in the midst of the next great upheaval in biological thinking...
23 April 2012 - by Ruth Pidsley 
Epigenetics has become something of a hot topic in recent years throughout the scientific community. 'Epigenetics: Linking Genotype and Phenotype in Development and Evolution', edited by Professors Benedikt Hallgrímsson and Brian Hall, reminds a new generation of molecular and systems biologists about the historical roots and scope of epigenetics...
5 March 2012 - by Dr Kimberley Bryon-Dodd 
A chemical that causes bad breath may help convert stem cells into liver cells, according to scientists in Japan...
10 October 2011 - by Oliver Timmis 
The Faroe Islands is set to become the first region to sequence the genome of its entire population....
3 October 2011 - by Suzanne Elvidge 
The European Commission (EC) is investing €30 million in BLUEPRINT, a project to map the human epigenome - the sum total of the non-coding, but inherited, modifications to DNA...
20 December 2010 - by Dr Carolina Gemma and Dr Vardhman Rakyan 
In recent years, significant progress has been made in identifying some of the genetic factors that underlie common complex diseases such as diabetes, obesity, hypertension and cancer. This has been possible due to the genome-wide association study (GWAS) approach that involves comparing genetic variants in large numbers of individuals that have the disease versus those that do not...
8 November 2010 - by Chris Chatterton 
New research suggests that the impact of stress may be passed on from one generation to the next, and that psychiatric illness may have some degree of 'epigenetic heritability'....
20 September 2010 - by Dr Gabrielle Samuel 
Scientists from the UK and China are collaborating to study epigenetic signatures that mark the differences between 5,000 twins. Those affected by diabetics and osteoporosis are just some of the people who could be set to benefit from the £20 million 'Epitwin' project....
19 July 2010 - by Dr Jay Stone 
The largest study to link cancer cells' genetics with their sensitivity to treatment published its first results on the 15 July...
28 June 2010 - by Dr Vivienne Raper 
The largest study of genetic differences between people to date - the 1,000 Genomes Project - has completed its pilot studies. The data is now freely available...
15 March 2010 - by Dr Will Fletcher 
Sequencing a patient's genome to find the genetic cause of their inherited disease has finally been proven to be a viable clinical approach in two recent independent studies. For some time gene sequencing has been heralded as ushering in a new era of medicine. However, until now, only around 10 people in the world had had their personal genomes sequenced in full, and all of these were healthy people. Now, in the ten years since the first full genome was sequenced (at a cost of ...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.